Overview
Purple Innovation Q3 2025 revenue missed analyst expectations despite slight year-over-year growth
Company reports improved net loss and positive adjusted EBITDA, reflecting profitability turnaround
Rejuvenate 2.0 and Mattress Firm expansion drive product and brand momentum
Outlook
Company maintains 2025 revenue guidance of $465 mln to $485 mln
Purple Innovation expects 2025 adjusted EBITDA of breakeven to $10 mln
Company cites Rejuvenate 2.0 and Mattress Firm partnership as growth drivers
Result Drivers
REJUVENATE 2.0 - Success of Rejuvenate 2.0 product line contributed to product and brand momentum
MATTRESS FIRM EXPANSION - Expansion of Mattress Firm partnership supported growth in premium segment
RESTRUCTURING BENEFITS - Completion of restructuring program led to cost savings and improved gross margins
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Miss | $118.76 mln | $123.20 mln (5 Analysts) |
Q3 Net Income | -$11.74 mln | ||
Q3 Gross Profit | $50.85 mln | ||
Q3 Operating Expenses | $62.97 mln | ||
Q3 Operating Income | -$12.12 mln | ||
Q3 Pretax Profit | -$11.69 mln |
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the home furnishings peer group is "buy."
Wall Street's median 12-month price target for Purple Innovation Inc is $3.30, about 75.8% above its November 3 closing price of $0.80
Press Release: ID:nPn5wQzf3a
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)